Vext Science, Inc.VEXT.CN
Key ratios
Operating cash flow growth
-34.3%TTM
2025
256.1%2024
-25.7%2023
-22.7%
EPS growth
-66.0%2023
FCF / Sales
6.8%TTM
2025
15.9%2024
5.1%2023
4.8%
Net margin
-28.4%TTM
2025
-35.0%2024
-62.3%2023
12.6%
ROA
-3.4%2025
2024
-4.9%2023
-3.6%
ROE
-28.0%2025
2024
-26.7%2023
5.3%
Revenue growth
14.8%TTM
2025
42.7%2024
3.4%2023
-1.7%
Recent news
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Vext Provides Operational Update on Jackson, Ohio Dispensary
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
Vext Announces Date for Q2 2026 Financial Results Release
Track VEXT.CN in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer